Healthy Returns: Eli Lilly’s chief scientific officer breaks down the latest obesity pill data ○
found
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Eli Lilly's Daniel Skovronsky talks the latest orforglipron trial, while UnitedHealth Group CEO Stephen Hemsley is moving quickly on a strategic turnaround.